Good laboratory practices for molecular genetic testing for heritable diseases and conditions.
about
Development and Characterization of Reference Materials for Genetic Testing: Focus on Public PartnershipsQuality assessment of the genetic test for familial hypercholesterolemia in the Netherlands.Refining the structure and content of clinical genomic reportsACMG clinical laboratory standards for next-generation sequencing.The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development.Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment dataDeveloping patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working groupQuality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel.Policy perspectives on the emerging pathways of personalized medicinePharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Health care providers and direct-to-consumer access and advertising of genetic testing in the United StatesQuality standards and samples in genetic testing.Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative ProjectThe laboratory-clinician team: a professional call to action to improve communication and collaboration for optimal patient care in chromosomal microarray testingThe Italian National External quality assessment program in molecular genetic testing: results of the VII round (2010-2011).Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.The perils of SNP microarray testing: uncovering unexpected consanguinity.Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical PracticeComprehensive genetic testing for primary immunodeficiency disorders in a tertiary hospital: 10-year experience in Auckland, New ZealandRecommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic).Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing.Health Care Infrastructure for Financially Sustainable Clinical Genomics.HIPAA's Individual Right of Access to Genomic Data: Reconciling Safety and Civil Rights.
P2860
Q28075594-C2AFE476-A27F-40FB-B69E-BCFF8C68C6B2Q30541806-110D536D-D360-4211-A863-045DB563B5B3Q33830276-76641D63-D65D-44BF-A6B5-75CCB0F4AA91Q33903280-1DD9D18F-69FF-4F41-A057-C1ADD40886FFQ33992261-76BB0D7E-D6EF-41E9-BC20-F78D2676E89CQ34234122-179FE79F-8ECB-4601-806E-64D8FDFF23EDQ34289301-36EB0B3B-A8E4-4AA1-BF27-A22298C0292FQ34309448-D38CC67D-783C-4EC7-B642-1EAABC4F7872Q34624868-255A91E1-726D-4B9D-9E61-36A849833039Q34960621-FAB0CFC1-7EDD-4112-9DC3-649FC00B1F78Q35083512-558092F9-BA6A-4D19-B098-B275D2AC32C2Q35237136-197ACCFA-E31A-45B2-808B-E1FF5E314AE7Q35812195-0238A01B-BACC-4AC3-93F9-D432D9BE7736Q35907523-4DEFCF09-F125-47F3-9842-6403D56F8BA5Q35914939-DD28C61E-2B73-4D63-A201-815C358D1B53Q36384580-F1C34557-FE48-48FF-99A3-47D59CC3A180Q36414582-5535C0B4-A116-406C-91FD-0E3CF5BA8E61Q36587904-B64D4359-CF3E-4E92-B609-D0EF807734EDQ36635133-84DA33F0-58BC-4B8C-A91D-05D60CDE8DE8Q36976975-41BCF8AE-233F-4323-8D93-6A3F96E143C0Q36987556-1196FC88-5CF6-4D8D-93E4-49DDA0E3F009Q37144518-CB15E546-966D-48A5-9F2D-074BD477E41DQ37480751-1BD207E6-8735-4720-9DE8-368BB046A82DQ37493098-410CEB64-495F-4FCE-B72C-5D9987F73251Q37608236-B77C7DA1-BAE7-469D-B949-F27D5EE8260CQ38378488-AD998B09-0ADA-4D17-B871-8A4FAB471A4EQ47198411-1B1CE117-6A42-44F0-886E-93805FA7763D
P2860
Good laboratory practices for molecular genetic testing for heritable diseases and conditions.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Good laboratory practices for ...... table diseases and conditions.
@ast
Good laboratory practices for ...... table diseases and conditions.
@en
type
label
Good laboratory practices for ...... table diseases and conditions.
@ast
Good laboratory practices for ...... table diseases and conditions.
@en
prefLabel
Good laboratory practices for ...... table diseases and conditions.
@ast
Good laboratory practices for ...... table diseases and conditions.
@en
P2093
P1476
Good laboratory practices for ...... itable diseases and conditions
@en
P2093
Devery A Howerton
Joe D Boone
MariBeth Gagnon
Nancy L Anderson
Shahram Shahangian
P304
1-37; quiz CE-1-4
P577
2009-06-01T00:00:00Z